Market Cap

Hypera SA Market Capitalization:

R$21.88 Billion

BRL as of Jan. 1, 2024

US$4.51 Billion

business Hypera SA Company Profile

Hypera SA Main Stock Listing

Bovespa: HYPE3

Market Capitalization History of Hypera SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Hypera SA market cap

Date Market Cap YoY Change
Jan. 1, 2024 R$21.88 B -18.70%
Jan. 1, 2023 R$26.91 B 38.67%
Jan. 1, 2022 R$19.41 B -3.65%
Jan. 1, 2021 R$20.14 B -9.22%
Jan. 1, 2020 R$22.19 B 11.68%
Jan. 1, 2019 R$19.87 B -12.36%
Jan. 1, 2018 R$22.67 B 30.02%
Jan. 1, 2017 R$17.44 B 25.06%
Jan. 1, 2016 R$13.94 B 22.80%
Jan. 1, 2015 R$11.35 B 19.34%
Jan. 1, 2014 R$9.51 B -11.34%
Jan. 1, 2013 R$10.73 B 61.96%
Jan. 1, 2012 R$6.63 B -46.47%
Jan. 1, 2011 R$12.38 B -8.61%
Jan. 1, 2010 R$13.54 B 288.37%
Jan. 1, 2009 R$3.49 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Hypera SA Categories

Brazil languages Healthcare languages Drug Manufacturers—Specialty & Generic
Brazil Healthcare Brazil Drug Manufacturers—Specialty & Generic

Stocks & Indices

Hypera SA has the following listings and related stock indices.


Stock: Bovespa: HYPE3

Stock: XSTU: HM6A

Stock: OTC: HYPMY

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.